Find the rare. Earlier.
Transforming the complexity of rare disease data into clarity, supporting earlier diagnosis and drug development decisions.
Built for care and research
Rarescope supports both clinical decision-making and pharmaceutical research by transforming complex patient data into structured, AI-assisted insights.
For healthcare providers
Rarescope helps clinicians identify potential rare disease risks earlier through AI-assisted patient profiling, risk analysis, and structured diagnostic support — designed to simplify complex clinical workflows and improve decision confidence.
Pharma research
For pharmaceutical & research teams
Rarescope supports rare disease research, patient stratification, and clinical trial initiatives with scalable AI models that surface meaningful patterns across fragmented patient data.
How it works
Rarescope combines patient data analysis, disease-specific AI models, and intuitive clinical workflows into a streamlined platform designed for faster and more informed decision-making.
AI model training
Configure and train a rare disease AI model through a guided step-by-step workflow, from data extraction and variable selection to factor analysis. Multi-chart data overviews make the training process transparent and auditable.
Patient profile modeling
Generate distinct patient profiles segmented by diagnosis patterns, clinical factors and treatment journeys. Scatter plot visualizations and HCP segmentation reveal the human diversity behind rare disease data.
Automated risk assessment
Score patients by rare disease risk level across geographic and clinical dimensions. Each patient receives a detailed symptom and demographic summary, turning raw data into actionable clinical insight.
Human-centered experiences for AI-driven healthcare
Combining intelligent analysis with intuitive interaction design, Rarescope creates workflows that feel approachable, efficient, and clinically focused.
Scalable across rare disease domains
Starting with 8 specialized disease models, Rarescope is designed as a flexible AI platform capable of supporting evolving diagnostic workflows, research initiatives, and future disease-specific model expansion.
- Duchenne Muscular Dystrophy
- Fabry Disease
- Huntington’s Disease
- Spinal Muscular Atrophy
- Pompe Disease
- Gaucher Disease
- Wilson’s Disease
- Ehlers–Danlos Syndrome
The future of rare disease intelligence
Discover how Rarescope combines AI-powered analysis and intuitive clinical workflows to support faster, more informed rare disease evaluation.
Request a demo